Evidence map›Paper›PMID 41446269›Full record

ArticlebioRxiv : the preprint server for biology2025

Functional modules predict cancer-relevant genetic interactions in mammalian cells.

Chenchu Lin, Veronica Gheorghe, Juihsuan Chou, Sabriyeh Alibai, Subin Kim, Esmaeili Anvar Nazanin, Yixin Xu, Xingdi Ma, Lori L Wilson, Russell D Moser and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chenchu LinDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Veronica GheorgheDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Juihsuan ChouDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sabriyeh AlibaiDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subin KimDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Esmaeili Anvar NazaninDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yixin XuDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Xingdi MaDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lori L WilsonDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Russell D MoserDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Christopher J KempDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Junjie ChenDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Scott KopetzDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Traver HartDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-1880-3341

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Exploring DNA damage response pathways as targets for cancer therapyR35CA274234 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Junjie Chen · 2022 to 2026
$4.4M
Identifying and targeting collateral lethal vulnerabilities in cancersU01CA275886 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RONALD ANTHONY DEPINHO, Traver Hart · 2023 to 2026
$3.9M
High-content microscopy platform for multiplex perturbation/multiplex readout studiesR35GM130119 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Traver Hart · 2018 to 2026
$3.9M
NCI NIH HHS P30 CA016672NCI NIH HHS R35 CA274234NCI NIH HHS U01 CA275886NIGMS NIH HHS R35 GM130119
6 · The paper itself

Abstract

Genetic interactions can reveal gene function and identify cancer-relevant synthetic lethals, but systematic mapping in human cells is constrained by inefficient reagents, vast combinatorial search space, and diversity of cell types. Here, we leverage principles from yeast genetic networks to identify human gene modules enriched for genetic interactions. Using our Cas12a-based In4mer combinatorial knockout platform, we screen all pairwise interactions within receptor tyrosine kinase and DNA damage response modules across eight diverse cancer cell lines. We identify hundreds of unreported synthetic lethals, including a dense network within the protein glycosylation machinery, and confirm that interactions in 2D cell culture are maintained in more physiologically relevant models. Our targeted modules show up to 16-fold enrichment of interaction density, providing a scalable strategy for systematic interaction mapping.

Identifiers

PMID41446269
PMCPMC12724552

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.